Flagship Pioneering Fund VII General Partner LLC - May 27, 2022 Form 3 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
10%+ Owner
Signature
Flagship Pioneering Fund VII General Partner LLC, By: Flagship Pioneering, Inc., its manager, By: /s/ Noubar B. Afeyan, Name: Noubar B. Afeyan, Ph.D., Title: Chief Executive Officer
Stock symbol
EVLO
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
3
Date filed
6/1/2022, 07:00 PM
Next filing
Jul 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EVLO Common Stock 13.7M May 27, 2022 By Flagship Pioneering Fund VII, L.P. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 27, 2022, Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 13,698,630 shares of the Issuer's Common Stock in registered direct offering at a price of $1.46 per share.
F2 Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the Chief Executive Officer, director and sole stockholder of Flagship Pioneering. Each of Flagship Fund VII GP, Flagship Pioneering and Dr. Afeyan disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.